Source: Indianweb2.com
Bengaluru – Leumas, a Bengaluru-based startup, secured $2.2 million in a new round of funding to expand its robotic factory services for pharmaceuticals and wellness companies. Capital 2B was the lead investor while Capital-A and Anicut Capital participated.
The company plans to use the funds to expand its research and development and to develop and broaden its modular manufacturing infrastructure to serve more brands and scale its operations across the country.
Founded in 2016 by Subhajit Biswas and Nitesh K, Leumas constructs software-powered robotic factories. These factories allow wellness and pharma brands to make products on-demand without investing in their own manufacturing units. It further allows for more flexibility, lower cost of manufacturing and faster-time-to-market.
Leumas provides two services – on-demand manufacturing and dedicated production suites. Both give companies access to smart, flexible production lines for products without having to own or operate traditional factories.
“Pharma and wellness brands today need more than just capacity. They need agility, traceability, and the ability to scale without being restricted by outdated infrastructure,” Leumas co founders said in a joint statement.
This recent investment puts Leumas’s total funding to $3.12 million. Leumas had raised INR 7 crore in a pre-seed round in 2023.
Leumas aims to target a growing $100 billion market through its factory-as-a-service solutions, enabling brands to produce smaller batches, respond faster to trends, and minimize waste. This model is particularly advantageous to new and smaller businesses faced with high production costs and lead time associated with traditional manufacturing systems.
A report from ResearchAndMarkets, Notes the pharmaceutical contract manufacturing industry was valued at $129.19 billion in 2024 and valued at $224.51 billion in 2030. The growth is driven by the need for personalized medicines as well as advanced wellness products and targeted therapeutics. These products require agile and efficient manufacturing systems to respond to continually changing needs.
At the same time, shifts in the world, such as the phenomenon of reshoring (bringing historical manufacturing back home) and uncertain geopolitical changes, are all resulting in search of more distributed and low-cost factory structures that can produce to demand.
Leumas is one of a handful of Indian startups trying to solve these issues by leveraging both technology and automation. Other companies working in this area include ASPO Pharmaceuticals, Janus Biotech, and Innovexia Life Sciences, to emphasize a few.
With this recent investment, Leumas will be in a strong position to scale their robotic factory model and be able to support even more brands in the pharma and wellness space.
